Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Announcing CHI’s NGS-Based Assays in the Clinical Setting Conference, Aug. 19-20, 2014, DCManaging the New Treatment Paradigm from Phenotype to Genotype
Conference sessions include: • Diagnosing genetic disorders with NGS • Interrogating cancer genes with NGS and microarray • NGS-based approaches to guide treatment • Interpretation of results • Making data actionable • Next-generation sequencing diagnostics Speakers include: Sami S. Amr, Ph.D., Harvard Medical School; Partners Center for Personalized Genetic Medicine Rong Chen, Ph.D., Icahn School of Medicine at Mount Sinai Robert D. Daber, Ph.D., Bio-Reference Laboratories Jennifer Dickey, RAC, Ph.D., US Food and Drug Administration Andrea Ferreira-Gonzalez, Ph.D., Virginia Commonwealth University Helen Fernandes, Ph.D., Weill Cornell Medical College Jeremy Goecks, Ph.D., George Washington University Wayne W. Grody, M.D., Ph.D., University of California Los Angeles School of Medicine Madhuri Hegde, Ph.D., FACMG, Emory University School of Medicine Christine M. Lovly, M.D., Ph.D., Vanderbilt Ingram Cancer Center Elaine Lyon, Ph.D., ARUP Raja Mazumder, Ph.D., The George Washington University Jennifer Morrissette, Ph.D., University of Pennsylvania Perelman School of Medicine Peter Nagy, Ph.D., Columbia University Donald “Will” Parsons, M.D., Ph.D., Texas Children’s Cancer Center Carol Saunders, Ph.D., FACMG, Children’s Mercy Hospital Peter J. Tonellato, Ph.D., Beth Israel Deaconess Medical Center and Harvard Medical School Writers and editors are invited to attend. To request a press pass, email Lisa Scimemi, lscimemi@healthtech.com. For more information, visit http://www.NextGenerationDx.com/ About Next Generation Dx Summit Access to next generation diagnostics will only be gained through careful creation and management of partnerships in the community around development, commercialization, reimbursement and regulation. This year’s Next Generation Dx Summit will showcase advances in personalized medicine through a comprehensive program encompassing companion diagnostics, infectious disease, cancer molecular markers, point-of-care, inherited disorders, cell free DNA and single cell sequencing. This event has become the meeting place for major players in the expanding arena of diagnostics. It will showcase key components of their successful adoption in the clinic and advancement to the market. http://www.NextGenerationDx.com About Cambridge Healthtech Institute (CHI) Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation. www.chicorporate.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|